Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
603 Targeted STAT3 degradation leads to remodeling of an immunosuppressive tumor microenvironment and subsequent sensitization to immune checkpoint therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.